Identification of a Polo-like Kinase 4-Dependent Pathway for De Novo Centriole Formation

被引:31
|
作者
Eckerdt, Frank [1 ]
Yamamoto, Tomomi M. [1 ]
Lewellyn, Andrea L. [1 ]
Maller, James L. [1 ]
机构
[1] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA
关键词
CYTOSTATIC FACTOR; METAPHASE ARREST; VERTEBRATE CELLS; XENOPUS EGGS; IN-VIVO; DUPLICATION; FERTILIZATION; LOCALIZATION; CENTROSOMES; EXTRACTS;
D O I
10.1016/j.cub.2011.01.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Supernumerary centrosomes are a key cause of genomic instability in cancer cells [1]. New centrioles can be generated by duplication with a mother centriole as a platform or, in the absence of preexisting centrioles, by formation de novo [2]. Polo-like kinase 4 (Plk4) regulates both modes of centriole biogenesis, and Plk4 deregulation has been linked to tumor development [1, 3]. We show that Plx4, the Xenopus homolog of mammalian Plk4 and Drosophila Sak, induces de novo centriole formation in vivo in activated oocytes and in egg extracts, but not in immature or in vitro matured oocytes. Both kinase activity and the polo-box domain of Plx4 are required for de novo centriole biogenesis. Polarization microscopy in "cycling" egg extracts demonstrates that de novo centriole formation is independent of Cdk2 activity, a major difference compared to template-driven centrosome duplication that is linked to the nuclear cycle and requires cyclinA/E/Cdk2. Moreover, we show that the Mos-MAPK pathway blocks Plx4-dependent de novo centriole formation before fertilization, thereby ensuring paternal inheritance of the centrosome. The results define a new system for studying the biochemical and molecular basis of de novo centriole formation and centriole biogenesis in general.
引用
收藏
页码:428 / 432
页数:5
相关论文
共 50 条
  • [21] Identification of a new centrosomal protein interacting with the Polo-like kinase
    Guarguaglini, G
    Duncan, PI
    Stierhof, YD
    Nigg, EA
    CELL MOTILITY AND THE CYTOSKELETON, 2003, 54 (02): : 177 - 177
  • [22] Identification of polo-like kinase as a therapeutic target in murine lupus
    Li, Yaxi
    Wang, Hongting
    Zhang, Zijing
    Tang, Chenling
    Zhou, Xinjin
    Mohan, Chandra
    Wu, Tianfu
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (01)
  • [23] Identification of β-catenin as a novel substrate of Polo-like kinase 1
    Arai, Tsuyoshi
    Haze, Kyosuke
    Iimura-Morita, Yuko
    Machida, Takumitsu
    Iida, Masato
    Tanaka, Kenji
    Komatani, Hideya
    CELL CYCLE, 2008, 7 (22) : 3556 - 3563
  • [24] Polo-like kinase 4: the odd one out of the family
    Sillibourne, James E.
    Bornens, Michel
    CELL DIVISION, 2010, 5
  • [25] Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
    Holland, Andrew J.
    Cleveland, Don W.
    CANCER CELL, 2014, 26 (02) : 151 - 153
  • [26] Chemical Probe for Imaging of Polo-like Kinase 4 and Centrioles
    Salim, Aleksandar
    Werther, Philipp
    Hatzopoulos, Georgios N.
    Reymond, Luc
    Wombacher, Richard
    Goenczy, Pierre
    Johnsson, Kai
    JACS AU, 2023, 3 (08): : 2247 - 2256
  • [27] Polo-like kinase 4: the odd one out of the family
    James E Sillibourne
    Michel Bornens
    Cell Division, 5
  • [28] NFκB regulates expression of Polo-like kinase 4
    Ledoux, Adeline C.
    Sellier, Helene
    Gillies, Katie
    Iannetti, Alessio
    James, John
    Perkins, Neil D.
    CELL CYCLE, 2013, 12 (18) : 3052 - 3062
  • [29] Polo-like kinase 4 phosphorylates Chk2
    Petrinac, Steve
    Ganuelas, Melissa L.
    Bonni, Sepal
    Nantais, Jordan
    Hudson, John W.
    CELL CYCLE, 2009, 8 (02) : 327 - 329
  • [30] IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF POLO-LIKE KINASE 2 AUTOREGULATORY SITES
    Rozeboom, A. M.
    Pak, D. T. S.
    NEUROSCIENCE, 2012, 202 : 147 - 157